Articles in section Licensing

<< Joint Venture

527 articles

Mergers & Acquisitions >>

<< Previous

Pages 1 ..2 3 4 5 6 7 .. 53

Next >>

Hookipa Pharma signs US$958 M Deal with Roche to develop HB-700 for KRAS-mutated Cancers Published: 5 Nov-2022
By: Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 11
Jazz Pharmaceuticals Enters into License Agreement with Zymeworks for Zanidatamab Published: 26 Oct-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 10
Bristol Myers Squibb Signs Protein Degradation and Cell Therapy Technology Deals Published: 8 Oct-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 10
Seagen Enters into License Agreement with Lava Therapeutics for LAVA-1223 Published: 7 Oct-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 10
Seagen Signs Collaboration and License Agreement with Zai Lab for Tivdak® Published: 6 Oct-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 10
Puma Biotechnology Enters into Licensing Agreement with Takeda for Alisertib Published: 6 Oct-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 10
Sanofi Collaborates with Scribe Therapeutics in CRISPR Cell Therapy Deal Published: 3 Oct-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 10
GSK Pays US$66 M Upfront for Spero’s Late-Stage Antibiotic Published: 29 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Zealand Pharma Signs Licensing Agreement with Novo Nordisk for Zegalogue® Published: 21 Sep-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 9
GSK Signs US$1.4 B ADC Option Deal with Mersana Published: 17 Aug-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 8

Login Problems

Please enter your username or email address and we will email you your login details.